Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Caligan Partners LP | 470.0K | $1.0M | 5.70% | -- | 2026-06-30 |
| Stempoint Capital LP | 354.9K | -- | 4.30% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 327.4K | -- | 3.97% | +245.5K | 2026-06-30 |
| Silverarc Capital Management, LLC | 321.7K | -- | 3.90% | -- | 2026-06-30 |
| Bleichroeder LP | 288.7K | -- | 3.50% | +188.7K | 2026-06-30 |
| Jupiter Topco LLC | 274.2K | -- | 3.32% | -- | 2026-06-30 |
| Balyasny Asset Management L.P. | 220.0K | -- | 2.67% | -- | 2026-06-30 |
| Nantahala Capital Management, LLC | 220.0K | -- | 2.67% | -- | 2026-06-30 |
| Empery Asset Management, LP | 189.6K | -- | 2.30% | -- | 2026-06-30 |
| Diadema Partners LP | 138.3K | -- | 1.68% | -- | 2026-06-30 |
